Cogstate Ltd (CGS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.235x

Based on the latest financial reports, Cogstate Ltd (CGS) has a cash flow conversion efficiency ratio of 0.235x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$11.24 Million ≈ $7.95 Million USD) by net assets (AU$47.90 Million ≈ $33.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cogstate Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Cogstate Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Cogstate Ltd (CGS) financial obligations for a breakdown of total debt and financial obligations.

Cogstate Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cogstate Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Tong-Tai Machine Tool Co Ltd
TW:4526
-0.067x
Global Partner Acquisition II Corp
NASDAQ:GPAC
0.297x
Orrön Energy AB (publ)
ST:ORRON
-0.015x
Evolus Inc
NASDAQ:EOLS
0.510x
Eaton Vance Floating Rate Income Closed Fund
NYSE:EFT
0.035x
SPCG Public Company Limited
BK:SPCG
0.013x
Kaimei Electronic Corp
TW:2375
0.007x
High Liner Foods Incorporated
TO:HLF
-0.061x

Annual Cash Flow Conversion Efficiency for Cogstate Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Cogstate Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Cogstate Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$47.90 Million
≈ $33.89 Million
AU$11.48 Million
≈ $8.12 Million
0.240x -10.20%
2024-06-30 AU$32.51 Million
≈ $23.00 Million
AU$8.67 Million
≈ $6.14 Million
0.267x +758.01%
2023-06-30 AU$56.62 Million
≈ $40.06 Million
AU$1.76 Million
≈ $1.25 Million
0.031x -88.94%
2022-06-30 AU$47.88 Million
≈ $33.88 Million
AU$13.45 Million
≈ $9.52 Million
0.281x -62.26%
2021-06-30 AU$29.02 Million
≈ $20.53 Million
AU$21.61 Million
≈ $15.29 Million
0.745x +1483.11%
2020-06-30 AU$22.49 Million
≈ $15.92 Million
AU$1.06 Million
≈ $748.66K
0.047x +11.42%
2019-06-30 AU$14.41 Million
≈ $10.20 Million
AU$608.36K
≈ $430.45K
0.042x +754.95%
2018-06-30 AU$15.81 Million
≈ $11.19 Million
AU$-101.94K
≈ $-72.13K
-0.006x -102.87%
2017-06-30 AU$14.45 Million
≈ $10.22 Million
AU$3.24 Million
≈ $2.29 Million
0.224x +17.69%
2016-06-30 AU$13.79 Million
≈ $9.76 Million
AU$2.63 Million
≈ $1.86 Million
0.191x +153.28%
2015-06-30 AU$7.76 Million
≈ $5.49 Million
AU$-2.78 Million
≈ $-1.96 Million
-0.358x -28.66%
2014-06-30 AU$12.25 Million
≈ $8.67 Million
AU$-3.41 Million
≈ $-2.41 Million
-0.278x -37.42%
2013-06-30 AU$8.04 Million
≈ $5.69 Million
AU$-1.63 Million
≈ $-1.15 Million
-0.202x -264.06%
2012-06-30 AU$10.46 Million
≈ $7.40 Million
AU$1.29 Million
≈ $913.45K
0.123x +62.94%
2011-06-30 AU$6.74 Million
≈ $4.77 Million
AU$510.19K
≈ $360.99K
0.076x -67.92%
2010-06-30 AU$5.97 Million
≈ $4.22 Million
AU$1.41 Million
≈ $996.85K
0.236x +2.85%
2009-06-30 AU$3.98 Million
≈ $2.82 Million
AU$914.58K
≈ $647.12K
0.230x +160.02%
2008-06-30 AU$1.84 Million
≈ $1.30 Million
AU$-704.54K
≈ $-498.50K
-0.382x +62.05%
2007-06-30 AU$1.34 Million
≈ $950.44K
AU$-1.35 Million
≈ $-957.86K
-1.008x -46.12%
2006-06-30 AU$2.30 Million
≈ $1.63 Million
AU$-1.58 Million
≈ $-1.12 Million
-0.690x -0.37%
2005-06-30 AU$2.92 Million
≈ $2.07 Million
AU$-2.01 Million
≈ $-1.42 Million
-0.687x -83.48%
2004-06-30 AU$4.23 Million
≈ $3.00 Million
AU$-1.59 Million
≈ $-1.12 Million
-0.375x --

About Cogstate Ltd

AU:CGS Australia Health Information Services
Market Cap
$291.33 Million
AU$411.73 Million AUD
Market Cap Rank
#15087 Global
#412 in Australia
Share Price
AU$2.40
Change (1 day)
-3.23%
52-Week Range
AU$1.25 - AU$2.92
All Time High
AU$2.92
About

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, includ… Read more